Skip to main content
. Author manuscript; available in PMC: 2019 Sep 10.
Published in final edited form as: Lancet Respir Med. 2016 Jan 21;4(2):107–115. doi: 10.1016/S2213-2600(15)00545-7

Figure 3.

Figure 3.

Absolute change from baseline in sweat chloride concentrations during the 24-week ivacaftor treatment period, presented as means and SD for each dose group at each time point